First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
Titel:
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
Auteur:
Aranda, E. García-Alfonso, P. Benavides, M. Sánchez Ruiz, A. Guillén-Ponce, C. Safont, M.J. Alcaide, J. Gómez, A. López, R. Manzano, J.L. Méndez Ureña, M. Sastre, J. Rivera, F. Grávalos, C. García, T. Martín-Valadés, J.I. Falcó, E. Navalón, M. González Flores, E. Ma García Tapiador, A. Ma López Muñoz, A. Barrajón, E. Reboredo, M. García Teijido, P. Viudez, A. Cárdenas, N. Díaz-Rubio, E.